Knock-down of CD30 was demonstrated to decrease the percentage of cells in S phase and increase the percentage in G0/G1 in the SU-DHL-1 ALK+ ALCL cell line [90], and found to decrease viability in cHL cell lines [96]. Here, TNFRSF8 is linked to classic Hodgkin lymphoma.